Kamal Kamal El Sayed Gadalla

Kamal Kamal El Sayed Gadalla

University of Edinburgh - Edinburgh / United Kingdom
Medical and Health Sciences / Pharmacology
AD Scientific Index ID: 1288491
person_outline Kamal Kamal El Sayed Gadalla's MOST POPULAR ARTICLES
1-) Improved survival and reduced phenotypic severity following AAV9/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout miceKKE Gadalla, MES Bailey, RC Spike, PD Ross, KT Woodard, SN Kalburgi, ...Molecular Therapy 21 (1), 18-30, 20131352013
2-) Radically truncated MeCP2 rescues Rett syndrome-like neurological defectsR Tillotson, J Selfridge, MV Koerner, KKE Gadalla, J Guy, D De Sousa, ...Nature 550 (7676), 398-401, 20171302017
3-) MeCP2 and Rett syndrome: reversibility and potential avenues for therapyKKE Gadalla, MES Bailey, SR CobbBiochemical Journal 439 (1), 1-14, 20111302011
4-) Development of a novel AAV gene therapy cassette with improved safety features and efficacy in a mouse model of Rett syndromeKKE Gadalla, T Vudhironarit, RD Hector, S Sinnett, NG Bahey, ...Molecular Therapy Methods & Clinical Development 5, 180-190, 20171002017
5-) Improved MECP2 gene therapy extends the survival of MeCP2-null mice without apparent toxicity after intracisternal deliverySE Sinnett, RD Hector, KKE Gadalla, C Heindel, D Chen, V Zaric, ...Molecular Therapy Methods & Clinical Development 5, 106-115, 2017902017